Skip to main content

Table 1 Summary of hypothetical scenarios used to evaluate cervical cancer prevention health states*

From: A survey of population-based utility scores for cervical cancer prevention

   Health state Description ( character name in health state description)
Cytology normal Pap test cytology negative (Kelly)
HPV vaccination Three doses of the HPV vaccine (Emily)
LG cytology Cytology screening with a low grade abnormality and a follow-up smear in 12 months (Lisa)
LG cytology with colposcopy normal Cytology screening with a low grade abnormality and immediate colposcopy (Andrea)
HPV positive with cytology normal HPV positive and cytology negative (to account for strategies involving either primary HPV screening with negative cytology triage or primary co-testing with HPV and cytology) (Danielle)
HPV positive with colposcopy normal HPV oncogenic positive with an immediate colposcopy which has a normal result (to account for primary HPV screening involving partial genotyping for HPV 16, 18 and immediate referral of this group) (Libby)
Treated genital warts Treatment for genital warts associated with HPV types 6 and 11 (Angela)
HG cytology with CIN 1 High grade abnormal cytology screening result with subsequent histologically-confirmed CIN Grade 1 (Natalie)
HG cytology with CIN 2 or 3 High grade abnormal cytology screening result with subsequent histologically-confirmed CIN Grade 2 or 3 (Deborah)
Early stage cervical cancer Early stage cervical cancer requiring a hysterectomy (Mary)
  1. * HPV human papillomavirus; LG low grade disease; HG high grade disease; CIN cervical intraepithelial neoplasia; FIGO Fédération Internationale de Gynécologie Obstétrique (International Federation of Gynecology and Obstetrics).